ASX:LBT LBT Innovations (LBT) Stock Price, News & Analysis → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free LBT Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume857,080 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield10.81%Price TargetN/A Stock AnalysisStock Analysis Get LBT Innovations alerts: Email Address Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About LBT Innovations Stock (ASX:LBT)LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring. The company's products pipeline also includes Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; Biofilm, a device for detecting the biofilms in the presence of mammalian tissues; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.Read More Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide LBT Stock News HeadlinesSeptember 12, 2022 | fool.com.auHere’s why LBT Innovations Limited shares rocketed 89% todayAugust 30, 2022 | ca.finance.yahoo.comIs LBT Innovations (ASX:LBT) Weighed On By Its Debt Load?May 11, 2024 | Crypto 101 Media (Ad)The Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.August 25, 2022 | msn.comWomen’s efforts for equality see a shift in SA’s landscapeAugust 11, 2022 | apnews.comBlack & Veatch Completes World’s First Commercial-Scale Alternative Animal Feed Production FacilityJuly 26, 2022 | ca.finance.yahoo.comWith 12.8% CAGR, Geospatial Analytics Market Worth USD 147.58 Billion by 2028June 10, 2022 | msn.comCheck Up: Biotechs are getting crushed, but expert says we shouldn’t dismiss themMay 14, 2022 | uk.finance.yahoo.comAKVA group ASA: Q1 2022 financial reportingMay 11, 2024 | Crypto 101 Media (Ad)The Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.May 10, 2022 | msn.comSenate approves Lisa Cook as first Black woman to Fed postMay 3, 2022 | msn.comClosing Bell: Interest piqued? Not for sliding local markets on Rates DayApril 30, 2022 | yahoo.comMonterey County Agricultural and Rural Life Museum celebrates agricultural historyApril 30, 2022 | yahoo.comArcelorMittal publishes 2021 integrated annual reviewMarch 25, 2022 | msn.comPMC gets over Rs215cr collected by stamp and registration deptJanuary 3, 2022 | msn.comASX Health Stocks: Imugene levels up in Phase 1 trial, Imricor slips into GreeceSeptember 28, 2021 | msn.comLBT Innovations (ASX:LBT) share price plummets 14% despite positive updateSeptember 27, 2021 | msn.comBRIEF-LBT Innovations Ltd Says Signs Distribution Agreement For Apas Independence In U.S. With Remel IncSeptember 27, 2021 | finance.yahoo.comClever Culture Systems Appoints Thermo Fisher Scientific as Exclusive US APAS® DistributorSeptember 27, 2021 | finance.yahoo.comDoes LBT Innovations (ASX:LBT) Have A Healthy Balance Sheet?See More Headlines Receive LBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LBT Innovations and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/26/2019Today5/11/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:LBT CUSIPN/A CIKN/A Webwww.lbtinnovations.com Phone61 8 8227 1555FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-21,380,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-197.95% Return on Assets-16.88% Debt Debt-to-Equity Ratio129.00 Current Ratio4.51 Quick Ratio2.10 Sales & Book Value Annual Sales$1.98 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow4.19 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,340,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.36 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Brenton John BarnesCEO, MD & DirectorMr. Raymond Robert Ridge B.A.BA (Acc), C.A., CA, GIA (cert), CFO, Company Secretary & DirectorDr. Steven GiglioScientific DirectorMr. Jack BrownCorporate Development DirectorKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersBrenton BarnesSold 1,031,250 sharesTotal: $24,750.00 ($0.02/share)Brenton BarnesSold 50,000,000 sharesTotal: $250,000.00 ($0.01/share) LBT Stock Analysis - Frequently Asked Questions How were LBT Innovations' earnings last quarter? LBT Innovations Limited (ASX:LBT) announced its quarterly earnings data on Tuesday, February, 26th. The company reported ($0.01) earnings per share for the quarter. This page (ASX:LBT) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LBT Innovations Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.